[email protected]

Contact UsCustom Services

CASC3 (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, BTZ, MLN51) (PE)

CAT:
544-MBS6409533-01
Size:
0.1 mL
Price:
Ask
Login for price
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
CASC3 (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, BTZ, MLN51) (PE) - image 1

Related Products

CAT

Name

MBS2123415-01Recombinant Prostate Cancer Susceptibility Candidate (PRAC)
MBS2086902-01Recombinant Cancer Susceptibility Candidate 5 (CASC5)
MBS2123414-01Recombinant Cancer Susceptibility Candidate 5 (CASC5)
MBS2086900-01Recombinant Cancer Susceptibility Candidate 1 (CASC1)
MBS2086901-01Recombinant Cancer Susceptibility Candidate 1 (CASC1)
MBS6409526-01CASC3 (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, BTZ, MLN51) (FITC)
MBS6409524-01CASC3 (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, BTZ, MLN51) (APC)
MBS6409525-01CASC3 (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, BTZ, MLN51) (Biotin)
MBS6409523-01CASC3 (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, BTZ, MLN51) (AP)
MBS6409527-01CASC3 (Cancer Susceptibility Candidate Gene 3 Protein Homolog, Metastatic Lymph Node Protein 51 Homolog, BTZ, MLN51) (HRP)

Alternative Products

CAT

Name

abx004578-01Cancer Susceptibility 3 (CASC3) Antibody
abx111351Cancer Susceptibility 3 (CASC3) Antibody
abx213746-01Cancer Susceptibility 3 (CASC3) Antibody
abx214020-01Cancer Susceptibility 3 (CASC3) Antibody
abx025070-01Cancer Susceptibility 3 (CASC3) Antibody
abx235220Cancer Susceptibility 3 (CASC3) Antibody
abx033281-01Cancer Susceptibility 3 (CASC3) Antibody
abx504817Rat Cancer Susceptibility 3 (CASC3) ELISA Kit
RPF262Mu01-50ugRecombinant Cancer Susceptibility Candidate 5 (CASC5)
RPU58166-01Recombinant Cancer Susceptibility Candidate 5 (CASC5)